NCT07019545
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- General Hospital of Athens "Alexandra", Athens, Attica Athens, Greece
Clinical trial condition
Thrombotic Microangiopathies
Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.
404 public trials
103 recruiting studies
Thrombotic Microangiopathies trial results
Not yet recruiting
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
NCT06873672
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +46 more
- Locations
-
- Guizhou Medical University Guiyang, Guizhou, China
NCT06790888
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified
Not yet recruiting
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified
Not yet recruiting
Aspirin for Prophylaxis of TTP
NCT05568147
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
- Locations
-
Not specified
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106
- Conditions
- Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Westmead Hospital Sydney, New South Wales, Australia
- Campbelltown Public Hospital Sydney, New South Wales, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
Enrolling by invitation
Comparative Autoantibody and Immunologic Cell Marker Study
NCT02422875
- Conditions
- Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, +85 more
- Locations
-
- Emory University Hospital Atlanta, Georgia, United States
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
- Grady Health System Atlanta, Georgia, United States
Active, not recruiting
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
NCT05885555
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Med Center Boston, Massachusetts, United States
- Novartis Investigative Site CABA, Argentina
- Novartis Investigative Site Garran, Australian Capital Territory, Australia
Active, not recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Investigator Site 0010116 Bentonville, Arkansas, United States
- Investigator site 0010045 Washington D.C., District of Columbia, United States
- Investigator Site 0010062 Fort Wayne, Indiana, United States
- Investigator site US0010042 Iowa City, Iowa, United States
Active, not recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04958265
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- University of Nebraska Omaha, Nebraska, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- UZ Gent Ghent, Belgium